San Diego, California — According to state and local economic development sources Abzena Biotech plans to invest $2,470,092.00 to build out 10,049 square feet of new space in San Diego. The company plans to occupy the new space at 6325 Lusk Blvd in San Diego, on or about April 1, 2020. According to the company website Abzena Biotech is a life sciences group with its headquarters in the UK and two sites in the US. Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and ADC drug development services in the pharmaceutical industry. Abzena Biotech is the worlds’ leading integrated A to Z integrated large molecules with long history of success from bench to bedside. Provides customized solution for Discovery to GMP Manufacture of biologics, peptides, ADC conjugate drugs, complex and highly potent molecules.

To learn more about Abzena Biotech, visit http://abzena.com/

Company Contact:
Jonathan Goldman, Chief Executive Officer
jonathan.goldman@abzena.com
https://www.linkedin.com/in/jonathan-goldman-md-mba-5358a67/
215-788-3603

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved